Scientists probe eye fluid to uncover why some macular degeneration patients Don't get better

This study looked at proteins in the eye fluid of 100 people with wet age-related macular degeneration (AMD). The goal was to measure certain growth factors that might explain why about 37% of patients do not respond well to standard anti-VEGF injections. Researchers collected a small sample of fluid from the front of the eye during a routine procedure. The study did not test any new drug, but aimed to gather information that could guide future treatments.